Aerovate Therapeutics Ownership | Who Owns Aerovate Therapeutics?
Aerovate Therapeutics Ownership Summary
Aerovate Therapeutics is owned by 95.78% institutional investors, 0.02% insiders, and 4.21% retail investors. Ra capital management is the largest institutional shareholder, holding 33.07% of AVTE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.84% of its assets in Aerovate Therapeutics shares.
AVTE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Aerovate Therapeutics | 95.78% | 0.02% | 4.21% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 9.19M | 33.07% | $15.26M |
| Sofinnova investments | 3.76M | 13.52% | $6.24M |
| Tcg crossover management | 2.24M | 8.06% | $3.72M |
| Atlas venture life science advisors | 1.80M | 6.47% | $2.99M |
| Deerfield management company, l.p. (series c) | 1.41M | 5.08% | $2.34M |
| Vanguard group | 1.11M | 3.98% | $1.83M |
| Blackrock | 983.06K | 3.54% | $1.63M |
| Artal group | 809.60K | 2.91% | $1.34M |
| Baker bros. advisors lp | 628.94K | 2.26% | $1.04M |
| Octagon capital advisors lp | 465.44K | 1.67% | $772.63K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tcg crossover management | 2.24M | 0.39% | $3.72M |
| Sofinnova investments | 3.76M | 0.32% | $6.24M |
| Atlas venture life science advisors | 1.80M | 0.31% | $2.99M |
| Ra capital management | 9.19M | 0.20% | $15.26M |
| Opaleye management | 440.00K | 0.17% | $730.40K |
| Octagon capital advisors lp | 465.44K | 0.12% | $772.63K |
| Fifth lane capital, lp | 50.00K | 0.12% | $83.00K |
| Nan fung group | 47.94K | 0.08% | $79.57K |
| Deerfield management company, l.p. (series c) | 1.41M | 0.04% | $2.34M |
| Affinity asset advisors | 200.00K | 0.04% | $332.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | 1.41M | 0.04% | 1.41M |
| Ra capital management | 9.19M | 0.20% | 928.11K |
| Artal group | 809.60K | 0.03% | 809.60K |
| Opaleye management | 440.00K | 0.17% | 440.00K |
| Vanguard group | 1.11M | - | 433.01K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Frazier life sciences management | - | - | -1.20M |
| Cormorant asset management, lp | - | - | -1.07M |
| Baker bros. advisors lp | 628.94K | 0.01% | -1.05M |
| Great point partners | - | - | -887.69K |
| Driehaus capital management | - | - | -794.99K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Deerfield management company, l.p. (series c) | 1.41M | 0.04% | 1.41M | $2.34M |
| Artal group | 809.60K | 0.03% | 809.60K | $1.34M |
| Opaleye management | 440.00K | 0.17% | 440.00K | $730.40K |
| Verition fund management | 248.95K | 0.00% | 248.95K | $413.26K |
| Affinity asset advisors | 200.00K | 0.04% | 200.00K | $332.00K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -2.00 |
| Russell investments group | -7.00 |
| Advisor group | -69.00 |
| Gamma investing | -80.00 |
| Fortitude family office | -416.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 77 | -17.20% | 27,644,291 | 1.70% | 95 | 1.00% | 39 | -37.10% | 16 | 14.29% |
| Jun 30, 2024 | 93 | 17.72% | 27,181,983 | -4.43% | 97 | 0.93% | 62 | 55.00% | 14 | -39.13% |
| Mar 31, 2024 | 79 | 25.40% | 28,443,127 | 0.96% | 102 | 0.89% | 40 | 29.03% | 23 | 35.29% |
| Dec 31, 2023 | 63 | 8.62% | 28,171,582 | -1.03% | 106 | 1.01% | 31 | 29.17% | 17 | 41.67% |
| Sep 30, 2023 | 58 | -3.33% | 28,465,427 | -0.03% | 102 | 0.80% | 24 | -11.11% | 12 | -7.69% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 531.54K | 1.84% | - |
| iShares Russell 2000 ETF | 450.26K | 1.56% | -1.01K |
| Vanguard VIF Small Co Gr | 290.43K | 1.01% | 44.85K |
| Vanguard Institutional Extnd Mkt Idx Tr | 202.52K | 0.70% | - |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 177.39K | 0.61% | - |
| Fidelity Small Cap Index | 135.61K | 0.47% | -459.00 |
| iShares Russell 2000 Growth ETF | 111.78K | 0.39% | - |
| Fidelity Extended Market Index | 72.31K | 0.25% | -104.84K |
| Voya Index Plus SmallCap Port I | 65.66K | 0.23% | - |
| Vanguard Russell 2000 ETF | 61.34K | 0.21% | -374.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 17, 2024 | RA CAPITAL MANAGEMENT, L.P. | Buy | $1.55M | |
| Jun 14, 2024 | Eldridge George A | SEE REMARKS | Sell | $375.45K |
| Jun 14, 2024 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | Sell | $265.00K |
| Jun 13, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | Sell | $147.00K |
| May 17, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | Sell | $82.45K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | - |
| 2024 Q2 | 1 | 29 |
| 2024 Q1 | - | 23 |
| 2023 Q4 | - | 12 |
| 2023 Q3 | - | 10 |
AVTE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools